BIO-FD&C Co.,Ltd.

₩8,550As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:251120Healthcare
Country South Korea
PE (Fwd) •••
TSR 5Y CAGR (15.46%)
Div yield —
ROE 9.19%
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.39
PE TTM 11.40
TSR TTM (48.02%)
Mkt cap ₩74.35B
ROIC 28.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,793
14.54%
(37.17%)
Hold 9|10|4|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
205.53
208.82
212.81
233.23
12.77%
15.37%
5.79%
16.08%
Revenue₩B
8.784
8.530
8.468
8.485
2.79%
(1.02%)
0.98%
(2.81%)
Peers (US$54.82M)
Cap (US$)
PE
54.82M
—
45.74M
8.277x
Capital
TTM
5Y
10Y
Leveragex
0.397
0.086
0.073
EBIT/Intx
0.924
0.185
0.187
Own earn%
(152.80)
27.24
28.07
Sh yield%
25.09
14.49
14.84
Owners
Insiders/Inst%
6.40
30.17
Short interest%
2.90
SBC / revenue%
3.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
5–20
$1 testx
—
Incr. ROIC%
60